Clinical Trials in Zhujiang, China
2 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 1
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Advanced Solid TumorRefractory Hodgkin Lymphoma
FBD Biologics Limited50 enrolled7 locationsNCT06487624
Recruiting
Phase 3
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
Chronic Myelomonocytic Leukemia
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.170 enrolled43 locationsNCT06647862
Recruiting
Phase 1Phase 2
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Malignant Neoplasm
Biotheus Inc.380 enrolled48 locationsNCT05918445